Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment‐Experienced Subjects: 48‐Week Results of the VICTOR‐E1 Phase 2 Trial
The Journal of Infectious Diseases2010Vol. 201(4), pp. 590–599
Citations Over TimeTop 10% of 2010 papers
Jamal Suleiman, Barry S. Zingman, Ricardo Sobhie Diaz, José Valdez Madruga, Edwin DeJesus, Jihad Slim, Carmen Mak, Erin Lee, Michael McCarthy, Lisa M. Dunkle, Sharon Walmsley
Abstract
NCT00243230 .
Related Papers
- → Two-Year Outcome of a Multidrug Regimen in Patients Who Did Not Respond to a Protease Inhibitor Regimen(2002)17 cited
- → Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure(1998)100 cited
- → Saquinavir Hard Gel Suppresses Viral Load Insufficiently in HIV-infected Patients Naive to Anti-retroviral Therapy: A Retrospective Cohort Study(1999)11 cited
- Half-full or half-empty: no simple answer on protease inhibitor failure.(1997)
- Protease inhibitors shine in triple combinations.(1996)